Page last updated: 2024-09-04

docetaxel anhydrous and Colorectal Neoplasms

docetaxel anhydrous has been researched along with Colorectal Neoplasms in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (13.16)18.2507
2000's9 (23.68)29.6817
2010's18 (47.37)24.3611
2020's6 (15.79)2.80

Authors

AuthorsStudies
Hao, YP; Liu, ZY; Ning, JF; Sun, X; Tang, ML; Zhou, L1
Chen, HC; Chen, SS; Dai, Z; He, YJ; Jin, DN; Jin, Q; Luo, XD; Wang, ZJ; Zhao, LX; Zhao, YL; Zhu, YY1
Han, R; Hao, Y; Hu, D; Liu, Q; Lu, Y; Peng, J; Qian, Z; Xiao, Y; Yuan, L1
Arias, FJ; Girotti, A; Gonzalez-Valdivieso, J; Rodriguez-Rojo, S; Santos, M; Schneider, J; Vallejo, R1
Agrawal, AK; Agrawal, S; Banach, J; Gamian, A; Makuch, S; Pielka, E; Pizon, M; Wietrzyk, J; Woźniak, M; Ziółkowski, P; Łuc, M1
Fabian, KP; Fujii, R; Hodge, JW; Padget, MR; Schlom, J1
Chu, D; Guo, J; Han, S; O'Driscoll, CM; Song, L; Sun, B; Sun, D; Wang, L; Xiao, F; Yu, Z; Zou, Y1
Chang, SY; Chin, YW; Heo, EY; Hong, EH; Jeon, SM; Kim, J; Ko, HJ; Kwon, BE; Lee, JY; Park, Y; Song, JH1
Andriana, BB; Matsuyoshi, H; Sato, H; Taketani, A1
Cicero, G; De Luca, R; Dieli, F1
Endo, K; Kuriyama, A1
Alomrani, AH; Ashour, AE; Badran, MM; Harisa, GI; Kumar, A; Yassin, AE1
Golmohammadzadeh, S; Hanafi-Bojd, MY; Jaafari, MR; Malaekeh-Nikouei, B; Mosallaei, N1
Beerling, E; Janssen, A; Medema, R; van Rheenen, J1
Ahuja, N; Azad, NS; Danilova, L; Delmas, A; Herman, JG; Pelosof, L; Yerram, SR1
Brock, MV; Fuks, F; Guo, M; Herman, JG; Li, Y; Wu, K; Yan, W; Yang, L; Yang, Y; Zhu, H1
Fan, R; Guo, G; Han, B; Luo, Y; Peng, X; Wang, Y; Wu, M; Zheng, Y; Zhou, L1
Brock, MV; Guo, J; Guo, M; Herman, JG; Linghu, E; Yang, Y; Zhan, Q; Zhang, B1
Barjat, H; Emmas, SA; Honndorf, VS; Pichler, BJ; Quintanilla-Martinez, L; Schmidt, H; Stahlschmidt, A; Wehrl, HF; Wiehr, S1
Fan, R; Gao, X; Guo, G; Li, X; Mei, L; Tong, A; You, C; Zhang, X; Zhou, L1
Hori, S; Seki, A1
Choi, HG; Kang, Y; Kim, IY; Kim, JA; Park, SY; Thapa, D1
Chen, J; Liu, B; Qian, X; Wang, T; Wei, J; Xie, L; Yu, L; Zou, Z1
Farsaci, B; Ferrone, S; Gameiro, SR; Garnett, CT; Hodge, JW; Palena, C; Tsang, KY1
Akiyama, T; Hirabayashi, Y; Hirai, T; Ikeda, M; Iki, K; Kubozoe, T; Matsumoto, H; Sadahira, Y; Tsunoda, T; Urakami, A; Yamamura, M; Yamashita, K1
Endo, Y; Fujiwara, T; Hioki, M; Ikeda, Y; Kagawa, S; Kishimoto, H; Sakai, R; Tanaka, N; Urata, Y1
Desai, K; Einstein, M; Fields, A; Goel, S; Goldberg, G; Macapinlac, M; Mani, S; Martin, R; Volterra, F; Wadler, S; Wong, B1
Boulikas, T; Erdmann, R; Fedier, A; Fink, D1
Geng, M; Ji, YB; Jiang, JS; Li, H; Lou, GY; Ma, T; Xi, WQ; Xia, HQ; YeE, ZB1
Bruntsch, V; Dirix, LY; Franklin, H; Kaye, SB; Le Bail, N; Pavlidis, NA; Smyth, JF; Sternberg, CN; ten Bokkel Huinink, WW; Wanders, S1
Abbruzzese, JL; Ajani, JA; Bready, B; Lassere, Y; Levin, B; Patt, Y; Pazdur, R; Soh, LT; Soo, E; Sugarman, S1
Rougier, P1
Andre, AM; Clark, TB; Conti, JA; Huang, Y; Kemeny, NE; Stockman, J1
Kobayashi, T; Maeda, Y; Okamoto, R; Omuro, Y; Sasaki, T; Takeda, N1
Blesch, K; Reigner, B; Weidekamm, E1
Prescott, LM1
Carpini, RD; Fedier, A; Fink, D; Haller, U; Schwarz, VA; Walt, H1
Sun, Y1

Reviews

4 review(s) available for docetaxel anhydrous and Colorectal Neoplasms

ArticleYear
Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colorectal Neoplasms; Docetaxel; Drugs, Chinese Herbal; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Quality of Life; Randomized Controlled Trials as Topic

2018
Docetaxel delivers new management opportunities for gastrointestinal carcinomas.
    Anti-cancer drugs, 1995, Volume: 6 Suppl 4

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids

1995
[New combination therapies for gastrointestinal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colorectal Neoplasms; Docetaxel; Fluorouracil; Humans; Irinotecan; Leucovorin; Paclitaxel; Prognosis; Stomach Neoplasms; Survival Analysis; Taxoids

2000
Clinical pharmacokinetics of capecitabine.
    Clinical pharmacokinetics, 2001, Volume: 40, Issue:2

    Topics: Antacids; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Food; Humans; Intestinal Absorption; Leucovorin; Liver Diseases; Paclitaxel; Protein Binding; Taxoids

2001

Trials

4 trial(s) available for docetaxel anhydrous and Colorectal Neoplasms

ArticleYear
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers.
    Investigational new drugs, 2006, Volume: 24, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colorectal Neoplasms; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Oligonucleotides; Pancreatic Neoplasms; Prothrombin Time; Taxoids

2006
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study.
    British journal of cancer, 1994, Volume: 70, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paclitaxel; Taxoids

1994
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Docetaxel; Drug Administration Schedule; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids

1994
Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma.
    Cancer investigation, 1998, Volume: 16, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Docetaxel; Female; Humans; Male; Middle Aged; Paclitaxel; Taxoids

1998

Other Studies

30 other study(ies) available for docetaxel anhydrous and Colorectal Neoplasms

ArticleYear
Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity.
    European journal of medicinal chemistry, 2020, May-01, Volume: 193

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Colorectal Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; HEK293 Cells; Humans; Male; Matrix Metalloproteinase 7; Mice; Mice, Inbred Strains; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Oligopeptides; Prodrugs; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2020
Neothalfine, a potent natural anti-tumor agent against metastatic colorectal cancer and its primary mechanism.
    Bioorganic & medicinal chemistry, 2021, 01-01, Volume: 29

    Topics: Antineoplastic Agents; Biological Products; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Structure-Activity Relationship

2021
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021, Volume: 8, Issue:24

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Caco-2 Cells; Colorectal Neoplasms; Disease Models, Animal; Docetaxel; Female; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Micelles

2021
CD44-targeted nanoparticles for co-delivery of docetaxel and an Akt inhibitor against colorectal cancer.
    Biomaterials advances, 2023, Volume: 154

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Colorectal Neoplasms; Docetaxel; Drug Carriers; Endothelial Cells; Mice; Nanoparticles; Proto-Oncogene Proteins c-akt

2023
Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2.
    Scientific reports, 2019, 11-12, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Caco-2 Cells; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Colorectal Neoplasms; Cyclophosphamide; Docetaxel; Down-Regulation; Drug Synergism; Female; Fluorouracil; GRB2 Adaptor Protein; Humans; Insulin; Irinotecan; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplastic Cells, Circulating; Oxaliplatin

2019
Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve.
    Journal for immunotherapy of cancer, 2021, Volume: 9, Issue:2

    Topics: Animals; Antineoplastic Agents, Immunological; Cell Line, Tumor; Colorectal Neoplasms; Combined Modality Therapy; Docetaxel; Female; Humans; Immune Checkpoint Inhibitors; Interleukin-15; Mice; Receptors, OX40; Recombinant Fusion Proteins; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Necrosis Factor Receptor Superfamily, Member 9; Vaccines, DNA; Xenograft Model Antitumor Assays

2021
A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.
    International journal of pharmaceutics, 2021, Sep-05, Volume: 606

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Cyclodextrins; Docetaxel; Folic Acid; Mice; Nanoparticles; Polyethylene Glycols; RNA, Small Interfering

2021
Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells.
    Oncotarget, 2017, Jun-20, Volume: 8, Issue:25

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Benzofurans; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Docetaxel; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred BALB C; Molecular Structure; Receptor, ErbB-2; Stilbenes; Taxoids; Tumor Burden

2017
Raman endoscopy for monitoring the anticancer drug treatment of colorectal tumors in live mice.
    The Analyst, 2017, Sep-25, Volume: 142, Issue:19

    Topics: Animals; Antineoplastic Agents; Cisplatin; Colorectal Neoplasms; Docetaxel; Endoscopy; Fluorouracil; Mice; Mice, Inbred BALB C; Spectrum Analysis, Raman

2017
Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer.
    Oncology, 2017, Volume: 93, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Docetaxel; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Phenylurea Compounds; Prednisone; Prostatic Neoplasms, Castration-Resistant; Pyridines; Quality of Life; Retrospective Studies; Taxoids; Treatment Outcome

2017
Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 106

    Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Survival; Chitosan; Colorectal Neoplasms; Delayed-Action Preparations; Docetaxel; Drug Carriers; Drug Compounding; Drug Liberation; Dynamic Light Scattering; HT29 Cells; Humans; Injections, Intraperitoneal; Lactic Acid; Male; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Taxoids; Technology, Pharmaceutical

2018
Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations.
    Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colon; Colorectal Neoplasms; Docetaxel; Drug Carriers; Female; Humans; Lipids; Melanoma; Mice; Mice, Inbred BALB C; Nanoparticles; Rectum; Taxoids

2013
Intravital FRET imaging of tumor cell viability and mitosis during chemotherapy.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Colorectal Neoplasms; Docetaxel; Enzyme Activation; Fluorescence Resonance Energy Transfer; Humans; Mice; Mitosis; Taxoids

2013
CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.
    International journal of cancer, 2014, Feb-01, Volume: 134, Issue:3

    Topics: Animals; Antineoplastic Agents; Base Sequence; Cell Cycle Proteins; Cell Line, Tumor; Colorectal Neoplasms; Deoxycytidine; DNA Methylation; DNA Primers; Docetaxel; Female; Gemcitabine; Gene Silencing; Humans; Mice; Microsatellite Instability; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Taxoids; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays

2014
Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.
    Epigenetics, 2013, Volume: 8, Issue:12

    Topics: Adenomatous Polyposis Coli; Animals; Cell Line, Tumor; Colorectal Neoplasms; DNA Methylation; Docetaxel; Drug Resistance, Neoplasm; Epigenesis, Genetic; Eye Proteins; Female; Gene Silencing; HCT116 Cells; Heterografts; Humans; Male; Mice; Neoplasm Transplantation; Signal Transduction; Taxoids; Transcription Factors; Transforming Growth Factor beta; Wnt Proteins

2013
Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis.
    International journal of biological macromolecules, 2014, Volume: 69

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Docetaxel; Drug Carriers; Lactic Acid; Male; Mice; Microspheres; Particle Size; Peritoneal Neoplasms; Poloxamer; Porosity; Taxoids; Xenograft Model Antitumor Assays

2014
RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.
    Oncotarget, 2015, Feb-28, Volume: 6, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; DNA Methylation; Docetaxel; Epigenesis, Genetic; Female; G2 Phase Cell Cycle Checkpoints; Genes, p53; Humans; M Phase Cell Cycle Checkpoints; Male; Mice; Mice, Inbred BALB C; Middle Aged; Promoter Regions, Genetic; Signal Transduction; Taxoids; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays

2015
The Synergistic Effect of Selumetinib/Docetaxel Combination Therapy Monitored by [(18)F]FDG/[(18)F]FLT PET and Diffusion-Weighted Magnetic Resonance Imaging in a Colorectal Tumor Xenograft Model.
    Molecular imaging and biology, 2016, Volume: 18, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Proliferation; Colorectal Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Docetaxel; Drug Synergism; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Immunohistochemistry; Mice; Positron-Emission Tomography; Taxoids; Xenograft Model Antitumor Assays

2016
Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; Apoptosis; Cathelicidins; Cell Line, Tumor; Colorectal Neoplasms; DNA Fragmentation; Docetaxel; Fluorescent Antibody Technique; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections, Intraperitoneal; Lactic Acid; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Peritoneal Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Polyesters; Polymers; Spectroscopy, Fourier Transform Infrared; Taxoids; Temperature; X-Ray Diffraction

2015
Transcatheter arterial chemoembolization with docetaxel-loaded microspheres controls heavily pretreated unresectable liver metastases from colorectal cancer: a case study.
    International journal of clinical oncology, 2011, Volume: 16, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoembolization, Therapeutic; Colorectal Neoplasms; Docetaxel; Female; Fluorouracil; Humans; Irinotecan; Liver Neoplasms; Microspheres; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Taxoids

2011
Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status.
    Archives of pharmacal research, 2011, Volume: 34, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Survival; Colorectal Neoplasms; Docetaxel; Genes, p53; Growth Differentiation Factor 15; HCT116 Cells; HT29 Cells; Humans; Molecular Targeted Therapy; Sulindac; Taxoids; Tumor Suppressor Protein p53; Up-Regulation

2011
Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines.
    BMC complementary and alternative medicine, 2012, Apr-30, Volume: 12

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Docetaxel; Drug Synergism; Herb-Drug Interactions; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Phytotherapy; Plant Extracts; RNA, Messenger; Stomach Neoplasms; Survivin; tau Proteins; Taxoids; Tubulin; Xanthones

2012
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
    International journal of cancer, 2013, Aug-01, Volume: 133, Issue:3

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calreticulin; Carcinoembryonic Antigen; Cell Line, Tumor; Colorectal Neoplasms; Cytotoxicity, Immunologic; Dendritic Cells; Docetaxel; eIF-2 Kinase; Female; HMGB1 Protein; Humans; Immunotherapy; Male; Mucin-1; Prostate-Specific Antigen; Prostatic Neoplasms; RNA Interference; RNA, Small Interfering; T-Lymphocytes, Cytotoxic; Taxoids

2013
In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer.
    International journal of clinical oncology, 2005, Volume: 10, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Camptothecin; Cisplatin; Colorectal Neoplasms; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; In Vitro Techniques; Irinotecan; Leucovorin; Male; Middle Aged; Mitomycin; Taxoids

2005
Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
    International journal of cancer, 2006, Jul-15, Volume: 119, Issue:2

    Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Colorectal Neoplasms; Docetaxel; Drug Carriers; Esophageal Neoplasms; Feasibility Studies; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasms; Polymerase Chain Reaction; Stomach Neoplasms; Taxoids; Telomerase; Transplantation, Heterologous; Vinblastine; Vinorelbine

2006
Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.
    International journal of oncology, 2006, Volume: 29, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antineoplastic Agents; Base Pair Mismatch; Carrier Proteins; Chromones; Cisplatin; Colorectal Neoplasms; DNA Repair; Docetaxel; Drug Resistance, Neoplasm; Humans; Inositol; Morpholines; MutL Protein Homolog 1; Nuclear Proteins; Organoplatinum Compounds; Oxaliplatin; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Taxoids; Tumor Cells, Cultured

2006
[In vitro chemo-sensitivity MTT assay guided intraperitoneal chemotherapy for malignant ascites].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ascites; Camptothecin; Cell Survival; Colorectal Neoplasms; Docetaxel; Female; Humans; Injections, Intraperitoneal; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured

2006
Highlights of the Eighth European Cancer Conference.
    Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:11

    Topics: Amifostine; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Colorectal Neoplasms; Combined Modality Therapy; Docetaxel; Head and Neck Neoplasms; Humans; Irinotecan; Neoplasms; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Taxoids; Vinblastine; Vinorelbine

1995
Resistance to topoisomerase poisons due to loss of DNA mismatch repair.
    International journal of cancer, 2001, Aug-15, Volume: 93, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Base Pair Mismatch; Breast Neoplasms; Carrier Proteins; Colorectal Neoplasms; Deoxycytidine; DNA Repair; DNA-Binding Proteins; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Enzyme Inhibitors; Epirubicin; Female; Gemcitabine; Humans; Intercalating Agents; Mitoxantrone; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Taxoids; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

2001
Clinical trials of new anticancer agents in recent years in China.
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29 Suppl 1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Clinical Trials as Topic; Colorectal Neoplasms; Docetaxel; Female; Humans; Lung Neoplasms; Male; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Taxoids; Vinblastine; Vinorelbine

2002